Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: geewiz who wrote (402)	10/31/1999 7:45:00 PM
From: geewiz	Read Replies (1) \| Respond to of 534

Very interesting layman's article on Biotech delivery platforms from last July 12th issue of Business Week. The link that follows may not link directly to story, so select July 12, 99 article titled "One Family's Story" For Private use only; Gene Therapy: One Family's Story The first attempts produced flickers of hope--but failed. For the Frohnmayer family, that left unrelenting grief. Now they're helping researchers fight the killer in their midst Dozens of companies are now involved in developing gene therapy. Treatments for heart disease are likely to be available in the next two to three years from Valentis, Vical, and Vascular Genetics, a subsidiary of Human Genome Sciences. Vical and Introgen Therapeutics are completing human trials of gene therapy for melanoma and head and neck cancer. Targeted Genetics has completed promising but preliminary human trials of gene therapy to treat cystic fibrosis, while Cell Genesys, Avigen, and Chiron Technologies are targeting hemophilia...... Vical Inc. and Vascular Genetics Inc. have dispensed with delivery systems altogether. They inject genes directly into muscle cells in a procedure as simple as administering a shot of penicillin. The naked DNA, as it's called, is taken up by some of the muscle cells, where the genes begin to function for at least a brief period...... businessweek.com Copywriter Business Week Magazine later, art